IRIS Accounts Production v24.3.2.46 04485751 Board of Directors Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary A 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh044857512023-09-30044857512024-09-30044857512023-10-012024-09-30044857512022-09-30044857512022-10-012023-09-30044857512023-09-3004485751ns15:EnglandWales2023-10-012024-09-3004485751ns14:PoundSterling2023-10-012024-09-3004485751ns10:Director12023-10-012024-09-3004485751ns10:Director22023-10-012024-09-3004485751ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3004485751ns10:SmallEntities2023-10-012024-09-3004485751ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3004485751ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3004485751ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3004485751ns10:FullAccounts2023-10-012024-09-3004485751ns10:OrdinaryShareClass12023-10-012024-09-3004485751ns10:CompanySecretary12023-10-012024-09-3004485751ns10:RegisteredOffice2023-10-012024-09-3004485751ns5:CurrentFinancialInstruments2024-09-3004485751ns5:CurrentFinancialInstruments2023-09-3004485751ns5:ShareCapital2024-09-3004485751ns5:ShareCapital2023-09-3004485751ns5:CapitalRedemptionReserve2024-09-3004485751ns5:CapitalRedemptionReserve2023-09-3004485751ns5:RetainedEarningsAccumulatedLosses2024-09-3004485751ns5:RetainedEarningsAccumulatedLosses2023-09-3004485751ns5:PlantMachinery2023-10-012024-09-3004485751ns5:FurnitureFittings2023-10-012024-09-3004485751ns5:ComputerEquipment2023-10-012024-09-3004485751ns5:PlantMachinery2023-09-3004485751ns5:FurnitureFittings2023-09-3004485751ns5:ComputerEquipment2023-09-3004485751ns5:PlantMachinery2024-09-3004485751ns5:FurnitureFittings2024-09-3004485751ns5:ComputerEquipment2024-09-3004485751ns5:PlantMachinery2023-09-3004485751ns5:FurnitureFittings2023-09-3004485751ns5:ComputerEquipment2023-09-3004485751ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3004485751ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3004485751ns5:WithinOneYear2024-09-3004485751ns5:WithinOneYear2023-09-3004485751ns5:BetweenOneFiveYears2024-09-3004485751ns5:BetweenOneFiveYears2023-09-3004485751ns5:AllPeriods2024-09-3004485751ns5:AllPeriods2023-09-3004485751ns5:DeferredTaxation2023-09-3004485751ns5:DeferredTaxation2024-09-3004485751ns10:OrdinaryShareClass12024-09-30
REGISTERED NUMBER: 04485751 (England and Wales)



UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

EDEN AESTHETICS DISTRIBUTION LIMITED

EDEN AESTHETICS DISTRIBUTION LIMITED (REGISTERED NUMBER: 04485751)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


EDEN AESTHETICS DISTRIBUTION LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: Dr H F Allan MBBS DCH MRCGP
Dr M Patterson MBBS DCH





SECRETARY: Dr H F Allan MBBS DCH MRCGP





REGISTERED OFFICE: Unit 2
Bell Works
Well Lane
Danbury
Essex
CM3 4AB





REGISTERED NUMBER: 04485751 (England and Wales)





ACCOUNTANTS: Lucentum Business Services Ltd
Beckwith Barn
Warren Estate
Lordship Road
Chelmsford
Essex
CM1 3WT

EDEN AESTHETICS DISTRIBUTION LIMITED (REGISTERED NUMBER: 04485751)

BALANCE SHEET
30 SEPTEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 32,156 44,029

CURRENT ASSETS
Stocks 6 303,587 452,478
Debtors 7 222,906 188,381
Cash at bank and in hand 8 121,653 360,014
648,146 1,000,873
CREDITORS
Amounts falling due within one year 9 571,925 756,997
NET CURRENT ASSETS 76,221 243,876
TOTAL ASSETS LESS CURRENT
LIABILITIES

108,377

287,905

PROVISIONS FOR LIABILITIES 11 6,110 8,364
NET ASSETS 102,267 279,541

CAPITAL AND RESERVES
Called up share capital 12 1,000 1,000
Capital redemption reserve 345 345
Retained earnings 100,922 278,196
SHAREHOLDERS' FUNDS 102,267 279,541

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

EDEN AESTHETICS DISTRIBUTION LIMITED (REGISTERED NUMBER: 04485751)

BALANCE SHEET - continued
30 SEPTEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 February 2025 and were signed on its behalf by:




Dr H F Allan MBBS DCH MRCGP - Director



Dr M Patterson MBBS DCH - Director


EDEN AESTHETICS DISTRIBUTION LIMITED (REGISTERED NUMBER: 04485751)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

Eden Aesthetics Distribution Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


Monetary amounts in these financial statements are rounded to the nearest £.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
In the application of the company's accounting policies, the directors are required to make judgments, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

There were no judgment or material estimation uncertainties affecting the reported financial performance in the current or prior year.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is recognised when the amount of revenue can be measured reliably, when it is probable that future economic benefits will flow to the entity and when specific criteria have been met.

Turnover represents net invoiced sales of medical equipment and products, excluding value added tax.Turnover is recognised when the goods are despatched to the customer.

EDEN AESTHETICS DISTRIBUTION LIMITED (REGISTERED NUMBER: 04485751)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

3. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 20% on reducing balance
Computer equipment - 33% on cost

Tangible fixed assets are initially measured at cost and subsequently measured at cost net of depreciation and any impairment losses. Depreciation of a tangible fixed asset begins when it is in the location and condition necessary available for the use intended.

Tangible fixed asset depreciation is included in administrative expenses in the Income Statement.

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Income Statement.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


EDEN AESTHETICS DISTRIBUTION LIMITED (REGISTERED NUMBER: 04485751)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in the Income Statement when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Investments
Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of Income and Retained Earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each Balance Sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

EDEN AESTHETICS DISTRIBUTION LIMITED (REGISTERED NUMBER: 04485751)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

3. ACCOUNTING POLICIES - continued

Impairment of non-financial assets
At each reporting date non-financial assets not carried at fair value, like plant, property and equipment, are reviewed to determine whether there is an indication that an asset may be impaired. If there is an indication of possible impairment, the recoverable amount of any asset or group of related assets, which is the higher of value in use and the fair value less cost to sell, is estimated and compared with its carrying amount. If the recoverable amount is lower, the carrying amount of the asset is reduced to its recoverable amount and an impairment loss is recognised immediately in profit or loss.

Stocks are also assessed for impairment at each reporting date. The carrying amount of each item of inventory, or group of similar items, is compared with its selling price less costs to complete and sell. If an item of inventory or group of similar items is impaired, its carrying amount is reduced to selling price less costs to complete and sell, and an impairment loss is recognised immediately in profit or loss.

If an impairment loss is subsequently reversed, the carrying amount of the asset or group of related assets is increased to the revised estimate of its recoverable amount, but not to exceed the amount that would have been determined had no impairment loss been recognised for the asset or group of related assets in prior periods. A reversal of an impairment loss is recognised immediately in profit or loss.

Going concern
Having considered the cash flow requirements of the company, for a period of at least twelve months from the approval of these financial statements, the directors are confident that sufficient financial resources will continue to be made available and that the company will be able to meet its debts as they fall due.

Accordingly these financial statements have been prepared on a going concern basis.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2023 - 11 ) .

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 October 2023
and 30 September 2024 39,334 75,914 37,458 152,706
DEPRECIATION
At 1 October 2023 10,721 70,637 27,319 108,677
Charge for year 7,153 1,063 3,657 11,873
At 30 September 2024 17,874 71,700 30,976 120,550
NET BOOK VALUE
At 30 September 2024 21,460 4,214 6,482 32,156
At 30 September 2023 28,613 5,277 10,139 44,029

EDEN AESTHETICS DISTRIBUTION LIMITED (REGISTERED NUMBER: 04485751)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

6. STOCKS
2024 2023
£    £   
Stocks 303,587 452,478

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 30,722 103,485
Other debtors 192,184 84,896
222,906 188,381

8. CASH AT BANK AND IN HAND
2024 2023
£    £   
Current account 57,547 156,316
Euro account 4,916 16,622
Dollar account 8,367 532
Bank deposit account 50,430 184,243
Cash in hand 393 2,301
121,653 360,014

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 55,551 303,462
Taxation and social security 100,232 76,704
Other creditors 416,142 376,831
571,925 756,997

10. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2024 2023
£    £   
Within one year 40,706 41,058
Between one and five years 69,111 109,817
109,817 150,875

11. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax
Accelerated capital allowances 6,110 8,364

EDEN AESTHETICS DISTRIBUTION LIMITED (REGISTERED NUMBER: 04485751)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

11. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 October 2023 8,364
Original and reversal (2,254 )
Balance at 30 September 2024 6,110

12. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1,000 Ordinary A £1 1,000 1,000

13. PENSION COMMITMENTS

The company operates a defined contribution pension scheme. The assets of the scheme are held separate from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund. Contributions payable to the fund at the year end by the company and included in other creditors are £NIL (2023: £3,149).

2024 2023
£ £

Contributions payable by the company for the year13,43310,971

14. RELATED PARTY DISCLOSURES

Other related parties

2024 2023
£ £
Purchases from a related party 35,215 87,024
Sales to a related party 349,057 307,633
Net amount due from/(to) related party 10,396 (33,15 )

The amounts shown above concern transactions with other companies in which Dr H F Allan and Dr M Patterson are directors and have a controlling interest.

15. ULTIMATE CONTROLLING PARTY

The company is under the control of Dr H F Allan and Dr M Patterson.